IMA vs J · rev $9.2M vs P/E 36, $14.40B cap
ImageneBio, Inc. (IMA) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
J does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the IMA and J stock pages for the full models.
Not investment advice.